Machine Learning Integrating <sup>99m</sup>Tc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors
The increasing evidence of oncocytic renal tumors positive in <sup>99m</sup>Tc Sestamibi Single Photon Emission Tomography/Computed Tomography (SPECT/CT) examination calls for the development of diagnostic tools to differentiate these tumors from more aggressive forms. This study combine...
Main Authors: | Michail E. Klontzas, Emmanouil Koltsakis, Georgios Kalarakis, Kiril Trpkov, Thomas Papathomas, Apostolos H. Karantanas, Antonios Tzortzakakis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/14/3553 |
Similar Items
-
Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT
by: Antonios Tzortzakakis, et al.
Published: (2017-03-01) -
Molecular Imaging Diagnosis of Renal Cancer Using <sup>99m</sup>Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
by: Octavian Sabin Tataru, et al.
Published: (2023-02-01) -
[<sup>99</sup>mTc]Sestamibi SPECT Can Predict Proliferation Index, Angiogenesis, and Vascular Invasion in Parathyroid Patients: A Retrospective Study
by: Nicoletta Urbano, et al.
Published: (2020-07-01) -
Role of <sup>11</sup>C-Methionine PET/CT in <sup>99m</sup>Tc-Sestamibi-Negative Parathyroid Adenoma: A Case Report
by: Jang Yoo, et al.
Published: (2021-05-01) -
A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia
by: Michail E. Klontzas, et al.
Published: (2023-08-01)